INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SB
Salzer BrunoDirector
ASAmer Sports, Inc.
Option exercise
M—
7,265 sh
May 8, 2026May 11, 2026
Page 837 of 1737
← PrevNext →
traded May 8, 2026
+3d
SEC Form 4

Evidence

9
SN
Steele NicolaChief Operating Officer
DNUTKrispy Kreme, Inc.
Tax withholding
F$30K
8,137 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
SF
Santhia Gian FrancoGroup Chief Financial Officer
ZGNErmenegildo Zegna N.V.
Option exercise
M—
15.6K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
17.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
PJ
Posadas Laura JDirector
KOPKoppers Holdings Inc.
Option exercise
M—
11 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
PL
Paterson LydiaDirector
UDMYUdemy, Inc.
Disposition to issuer
D—
95.2K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
VA
Villanueva Rodriguez AlfonsoEVP&Int.Group CEO-VZ Cons.&CTO
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,046
78 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
HH
Hiles HeatherDirector
UDMYUdemy, Inc.
Disposition to issuer
D—
70.1K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
NR
Niebergall RossDirector
VVXV2X, Inc.
Option exercise
M—
838 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
FT
Fleming John TurmanDirector
USNAUSANA HEALTH SCIENCES INC
Grant or award
A—
6,527 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
7,999 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
FE
Farnsworth David E.Director
VVXV2X, Inc.
Grant or award
A—
2,188 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
WC
Walker Helgi C.Director
BFSSAUL CENTERS, INC.
Grant or award
A—
2,000 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
SB
Shah Mitesh BansilalSVP and CHRO
VMCVulcan Materials CO
Grant or award
A—
3,607 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
BR
Bazarko Anthony R.Chief Commercial Officer
SEERSeer, Inc.
Grant or award
A—
75.0K sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
SH
Sarrazin HugoDirector, President and CEO
UDMYUdemy, Inc.
Disposition to issuer
D—
1.40M sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
CS
Clay ShaundraDirector
IARTINTEGRA LIFESCIENCES HOLDINGS CORP
Grant or award
A—
17.7K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
PJ
Posadas Laura JDirector
KOPKoppers Holdings Inc.
Option exercise
M—
11 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
24.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,052 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
HC
Hogan Thomas ChristopherEVP/CLO & Corp Secretary
CINFCINCINNATI FINANCIAL CORP
Option exercise
M—
487 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
YM
Yeshoalul MelonSVP and CHRO
VVXV2X, Inc.
Option exercise
M—
1,545 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
CK
Campbell Kotzman KellyDirector
NCMINational CineMedia, Inc.
Grant or award
A—
32.3K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
10.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
12.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
16.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
11.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
TA
Tagliabue Gianluca AmbrogioActing Group CEO
ZGNErmenegildo Zegna N.V.
Option exercise
M—
47.3K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
HJ
Harris Ian JiroDirector
CTLPCANTALOUPE, INC.
Disposition to issuer
D—
168.7K sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
NR
Niebergall RossDirector
VVXV2X, Inc.
Grant or award
A—
2,188 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
DX
Ding XiaDirector
USNAUSANA HEALTH SCIENCES INC
Grant or award
A—
6,527 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,899 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
4,999 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,899 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

8
RG
Rubenstein GordonDirector
ACELAccel Entertainment, Inc.
Gift
G—
9,000 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

8
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
229 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

8
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
230 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

8
WL
Walsh Elizabeth L.Director
CARECarter Bankshares, Inc.
Gift
G—
725 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

7
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$184K
18.6K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

7
BJ
Buonanno Franck JeanVice-President, Global Sales
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$200
20.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence